Mr. Olivier Charmeil was Senior Vice President Vaccines, Member of the Executive Committee and Global Leadership Team of Sanofi SA since January 1, 2011. He joined the Company as Senior Vice President Pharmaceutical Operations in AsiaPacific Region on February 1, 2006, the function he held until January 1, 2008, when he became appointed Senior Vice President Pharmaceutical Operations in Asia Pacific Region and Japan for over one year, until February 2009. From then to January 1, 2011, he served as Senior Vice President Asia/Pacific & Japan Vaccines, Member of the Management Committee of the Company. From 1989 to 1994, he worked in the Mergers and Acquisitions department of Banque de l?Union Europeenne. He joined Sanofi Pharma in 1994 as Head of Business Development. Subsequently, he held various posts within the Group, including Chief Financial Officer for SanofiSynthelabo in 1999 and Attache to the Chairman, JeanFrancois Dehecq, in 2000, before being appointed as Vice President of Development within the SanofiSynthelabo International Operations Division, where he was responsible for China and support functions. In 2003, Mr. Charmeil was appointed Chairman and Chief Executive Officer of SanofiSynthelabo France, before taking the post of Senior Vice President of Business Management and Support within the Pharmaceutical Operations Division. Mr. Charmeil obtained a degree from the Hautes etudes commerciales and from the Institut d'Etudes Politiques de Paris.
Senior Vice President - Vaccines, Member of the Executive Committee and Global Leadership Team
Age: 49 President Since 2011
The company has Return on Asset of 4.95 % which means that on every $100 spent on asset it made $4.95 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.02 % implying that it generated $9.02 on every 100 dollars invested.
The company has 18.82 B in debt with debt to equity (D/E) ratio of 0.25 which may show that the company is not taking advantage of profits from borrowing. Sanofi has Current Ratio of 1.62 which is typical for the industry and considered as normal.
Entity SummarySanofi researches, develops, manufactures, and markets healthcare solutions worldwide. Sanofi [SNY] is traded on New York Stock Exchange in USA. It is located in , Rue La BoParis, and employs 111,974 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| SNY NYSE
Sanofi has less than 15.64 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Sanofi price boundaries
Promote Sanofi and Olivier Charmeil